Cargando…

Correction : Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies

Detalles Bibliográficos
Autores principales:	McNicholas, Bairbre A., Rezoagli, Emanuele, Simpkin, Andrew J., Khanna, Sankalp, Suen, Jacky Y., Yeung, Pauline, Brodie, Daniel, Bassi, Gianluigi Li, Pham, Tai, Bellani, Giacomo, Fraser, John F., Laffey, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214330/ https://www.ncbi.nlm.nih.gov/pubmed/37237395 http://dx.doi.org/10.1186/s13054-023-04487-6

Ejemplares similares

Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies
por: McNicholas, Bairbre A., et al.
Publicado: (2023)

Emerging pharmacological therapies for ARDS: COVID-19 and beyond
por: Horie, Shahd, et al.
Publicado: (2020)

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
por: Gandini, Lucia, et al.
Publicado: (2023)

ARDS RELATED TO COVID-19
por: Sekhon, Jasmine, et al.
Publicado: (2020)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

The discovery of biological subphenotypes in ARDS: a novel approach to targeted medicine?
por: Wildi, Karin, et al.
Publicado: (2021)

Missed or delayed diagnosis of ARDS: a common and serious problem
por: Bellani, Giacomo, et al.
Publicado: (2020)

Correction to: The discovery of biological subphenotypes in ARDS: a novel approach to targeted medicine?
por: Wildi, Karin, et al.
Publicado: (2021)

Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
por: Li Bassi, Gianluigi, et al.
Publicado: (2022)

The Safety and Efficiency of Addressing ARDS Using Stem Cell Therapies in Clinical Trials
por: Rezoagli, Emanuele, et al.
Publicado: (2019)

Death in hospital following ICU discharge: insights from the LUNG SAFE study
por: Madotto, Fabiana, et al.
Publicado: (2021)

External chest-wall compression in prolonged COVID-19 ARDS with low-compliance: a physiological study
por: Bastia, Luca, et al.
Publicado: (2022)

The Severe ARDS Generating Evidence (SAGE) Study: A Call for Action in the Daily Clinical Practice
por: Rezoagli, Emanuele, et al.
Publicado: (2021)

COVID-19 ARDS-related pneumomediastinum and pneumothorax
por: Marwah, Vikas, et al.
Publicado: (2021)

Future therapies for ARDS
por: Curley, Gerard F., et al.
Publicado: (2014)

COVID-19-Related ARDS: Key Mechanistic Features and Treatments
por: Selickman, John, et al.
Publicado: (2022)

Presence of comorbidities alters management and worsens outcome of patients with acute respiratory distress syndrome: insights from the LUNG SAFE study
por: Rezoagli, Emanuele, et al.
Publicado: (2022)

The LUNG SAFE study: a presentation of the prevalence of ARDS according to the Berlin Definition!
por: Bellani, Giacomo, et al.
Publicado: (2016)

Lung transplantation for severe COVID-19-related ARDS
por: Ko, Ryoung-Eun, et al.
Publicado: (2022)

METABOLOMIC PROFILING AND PROGNOSTICATION IN COVID-19-RELATED ARDS
por: FURFARO, DAVID, et al.
Publicado: (2022)

IL-6 serum level, ARDS, and AKI as risk factors for the COVID-19 infection’s mortality in children
por: Ganda, Idham Jaya, et al.
Publicado: (2023)

COVID-19 pneumonia: ARDS or not?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

COVID-19 ARDS: getting ventilation right – Authors' reply
por: Barbaro, Ryan P, et al.
Publicado: (2022)

Early bacterial co-infection in ARDS related to COVID-19
por: Kreitmann, Louis, et al.
Publicado: (2020)

Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS
por: Jouan, Youenn, et al.
Publicado: (2021)

ECMO for ARDS due to COVID-19
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

Incidence, Risk Factors, and Consequences of Post-Traumatic Stress Disorder Symptoms in Survivors of COVID-19-Related ARDS
por: Miori, Sara, et al.
Publicado: (2023)

RESPIRATORY PHYSIOLOGICAL PARAMETERS AND OUTCOMES OF PATIENTS WITH COVID-19 ARDS AND NON-COVID-19 ARDS UNDERGOING ECMO
por: FEDERBUSH, M., et al.
Publicado: (2022)

Successful continuation of pregnancy in a patient with COVID-19-related ARDS
por: Federici, Laura, et al.
Publicado: (2020)

Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS
por: Lamouche-Wilquin, Pauline, et al.
Publicado: (2022)

Prone positioning in COVID-19 acute respiratory failure: just do it?
por: McNicholas, Bairbre, et al.
Publicado: (2020)

Complexity and unanswered questions in the pathophysiology of COVID-19 ARDS
por: Chiumello, Davide, et al.
Publicado: (2021)

COVID-19 and ARDS: the baby lung size matters
por: Gattinoni, Luciano, et al.
Publicado: (2020)

The effect of driving pressures in COVID-19 ARDS: Lower may still be better as in classic ARDS
por: Yildirim, Süleyman, et al.
Publicado: (2021)

Atypical Presentation of COVID-19 Leading to ARDS
por: Williams, Aquino, et al.
Publicado: (2020)

Mechanical ventilation in early COVID-19 ARDS
por: Lepper, Philipp M., et al.
Publicado: (2020)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Lung transplantation for COVID-19-associated ARDS
por: Lepper, Philipp M, et al.
Publicado: (2021)

Lung transplantation for COVID-19-associated ARDS
por: Messika, Jonathan, et al.
Publicado: (2021)

COVID-19 ARDS: getting ventilation right
por: Pérez-Fernández, Xosé L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1elgefbslnhpvob04abke7q8l6